2000
DOI: 10.1073/pnas.98.1.87
|View full text |Cite
|
Sign up to set email alerts
|

Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin

Abstract: Trichostatin A (TSA) and trapoxin (TPX) are potent inhibitors of histone deacetylases (HDACs). TSA is proposed to block the catalytic reaction by chelating a zinc ion in the active-site pocket through its hydroxamic acid group. On the other hand, the epoxyketone is suggested to be the functional group of TPX capable of alkylating the enzyme. We synthesized a novel TPX analogue containing a hydroxamic acid instead of the epoxyketone. The hybrid compound cyclic hydroxamic acid-containing peptide (CHAP) 1 inhibit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
110
0
3

Year Published

2001
2001
2014
2014

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 354 publications
(122 citation statements)
references
References 47 publications
4
110
0
3
Order By: Relevance
“…It is possible that HDAC6, due to its association with HDAC11 in vivo, is contributing to the observed in vitro enzymatic activities. However, HDAC6's enzymatic activity is highly resistant to trapoxin (43), whereas the activity derived from immunoprecipitated HDAC11 is completely inhibited at 200 nM. Therefore, we conclude that HDAC11 is a bona fide histone deacetylase.…”
Section: Discussionmentioning
confidence: 81%
“…It is possible that HDAC6, due to its association with HDAC11 in vivo, is contributing to the observed in vitro enzymatic activities. However, HDAC6's enzymatic activity is highly resistant to trapoxin (43), whereas the activity derived from immunoprecipitated HDAC11 is completely inhibited at 200 nM. Therefore, we conclude that HDAC11 is a bona fide histone deacetylase.…”
Section: Discussionmentioning
confidence: 81%
“…Histone deacetylase enzyme activities are inhibited by TSA through direct interaction of TSA with histone deacetylases (52,53). TSA increases the acetylation level and transcriptional activity in p53 (51).…”
Section: Discussionmentioning
confidence: 99%
“…The treatment of mammalian cells with potent inhibitors of HDACs such as TSA or trapoxin was shown to result in increased expression of a variety of genes (Kijima et al, 1993;Yoshida et al, 1995). At very low concentrations, inhibitors of HDACs induce hyperacetylation of core histones, which is accompanied by characteristic blockage of the cell cycle as well as by various cellular phenotypic changes (Medina et al, 1997;Dangond and Gullans, 1998;Chen and Townes, 2000;Furumai et al, 2001). Usually, TSA is used only as an HDACs inhibitor to increase acetylation of core histones, but whether TSA induces phosphorylation of core histones remain to be determined.…”
Section: Discussionmentioning
confidence: 99%